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INTRODUCTION
Pulmonary edema is a common cause of dyspnea and a leading 
reason for inpatient admission. Pulmonary edema results from accu-
mulation of fluid or proteins in the alveoli, resulting in a ventilation 
perfusion mismatch, hence resulting in shortness of breath.1 The 
principal mechanisms underlying formation of pulmonary edema 
are transudation of protein poor fluid into the pulmonary interstitial 
and alveolar spaces, as happens in cardiogenic pulmonary edema; and 
increased permeability of the pulmonary endothelium as happens in 
non-cardiogenic causes such as acute respiratory distress syndrome 
(ARDS).1-3
Pulmonary edema etiology can be divided into cardiogenic and 
non-cardiogenic classes. By far, heart diseases are the leading cause 
of pulmonary edema in inpatient services.2 Non-cardiogenic pulmo-
nary edema commonly is associated with acute respiratory distress 
syndrome and pulmonary embolism.4 Distant organ dysfunction such 
as renal failure is emerging as a cause of pulmonary edema, especially 
with widespread access to hemodialysis services and enhanced sur-
vival.5 Noncompliance with this lifesaving procedure, as is common 
with many medical prescriptions, is the leading reason for this associ-
ation. This case report detailed a dramatic presentation of pulmonary 
edema due to noncompliance with hemodialysis.
CASE REPORT
A 50-year-old, African American male with a past medical history 
of end stage renal disease (ERSD) on hemodialysis presented to the 
emergency department with shortness of breath, exertional dyspnea 
(New York Heart Association Class IV), weight gain, bilateral leg 
edema, and new-onset hemoptysis. He reported to have missed a 
hemodialysis session, making his last session about seven days prior 
to presentation. He denied fever and recent flu-like illness. He had 
no previous history of heart disease or congestive heart failure. On 
presentation, he was sickly, but with a normal temperature and heart 
rate. He had tachypnea with a respiratory rate of 22 breaths per 
minute and elevated blood pressure of 197/93 mmHg. He had pulse 
oximetry reading of 64% on room air. He was placed on 15 L of oxygen 
on a non-rebreather mask. Physical examination revealed edema, 
jugular venous distention, and an S3 gallop on cardiac auscultation. 
Pulmonary auscultation revealed crackles in the lower lung fields 
bilaterally, decreased aeration in the upper lung fields bilaterally, and 
diffuse expiratory wheezes. The patient had anasarca and bilateral 
lower extremity pitting edema. Significant blood was seen on exami-
nation of the patient’s sputum. 
Noteworthy laboratory findings included a white blood cell count 
of 17.2x10x3/L, hemoglobin 14.6 g/dL, blood urea nitrogen 61 mg/dL, 
serum creatinine 10.9 mg/dL, procalcitonin 5.26 ng/mL, brain natri-
uretic peptide (BNP) 480 pg/mL, and lactic acid 4.3 mmol/L. The 
admission chest x-ray (Figure 1) and a computerized tomography 
(CT) angiogram (Figure 2) ruled out pulmonary emboli but revealed 
multi-lobar airspace opacities. A 2-D transthoracic echocardiogram 
revealed an ejection fraction of 65%, grade 2 diastolic dysfunction, 
and pulmonary artery pressure was estimated at 90 mmHg. There 
were no valve regurgitations or stenosis noted on Doppler echo.
Figure 1. Admission chest x-ray showed cardiomegaly and bilateral pulmonary 
alveolar infiltrates.
Figure 2. Admission CT angiogram showed diffuse multi-lobar airspace opaci-
ties. 
Figure 3. Day 3 chest x-ray showed stable cardiomegaly and improvement of 
pulmonary infiltrates after two days of hemodialysis.
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continued.
The patient was started on antibiotics for possible health-
care-associated pneumonia and received hemodialysis for three 
consecutive days. His hemoptysis resolved after the first session of 
hemodialysis and, after two days of dialysis treatment, his physical 
exam was improved with resolved edema, jugular venous distension, 
and crackles on lung auscultation. A repeat chest x-ray was done on 
Day 3 of admission (Figure 3), which showed significant improve-
ment in the pulmonary infiltrates.
DISCUSSION
Pulmonary edema results from fluid or protein accumulation 
in the alveoli, largely from processes that alter the Starling forces, 
changing the net flow of liquids across a membrane.1-3 The distinc-
tion between cardiogenic and non-cardiogenic pulmonary edema 
often is difficult. History and examination are often similar and mea-
surement of pulmonary artery pressure of less than 25 mmHg on 
echocardiography and right heart catheterization measurement of 
the pulmonary capillary wedge pressure level less than 18 mmHg 
predicts non-cardiogenic causes. 
Non-cardiogenic pulmonary edema is often secondary to acute 
respiratory distress syndrome, high altitude, opioid overdose, pulmo-
nary embolism, and in our case, renal failure.5,6 Accumulation of fluid 
in the lungs among renal failure patients results from down regulation 
of the epithelial salt-water transporters such as ENaC, sodium-potas-
sium ATPase and aquaporin-5 in the lung. These transporters are 
responsible for sodium absorption from the alveolar cavity into the 
alveolar epithelium cells, with water following passively.5 Addition-
ally, accumulation of inflammatory cytokines (such as interleukins 
IL-6, IL-8, IL-1β), tumor necrosis factor α, macrophage inflamma-
tory protein 2, nuclear factor-κB, chemokines, and activated innate 
immune cells in acute and chronic kidney injury have been theorized 
to provoke and initiate pathological cascades that leads to acute lung 
injury and ARDS.7
Patients with pulmonary edema generally present with dyspnea, 
bilateral lower-extremity edema, and chest radiographs showing 
bilateral alveolar filling patterns.4 Hemoptysis, as in the above case, is 
an uncommon presenting symptom. The management of pulmonary 
edema involves treatment of the underlying disease and supportive 
measures, such as mechanical ventilation, maintenance of adequate 
nutrition, and lowering the pulmonary artery wedge pressure with 
diuretics, ultrafiltration (during hemodialysis), and fluid restriction.
Since our patient had severe hypertension and normal ejection 
fraction, it is possible diastolic dysfunction contributed at least in 
part to the pulmonary edema. Moreover, our patient had no mitral 
stenosis or regurgitation. However, the dramatic improvement in his 
symptoms following hemodialysis implied, at least to some degree, 
that the pulmonary edema was volume dependent in the setting of 
hemodialysis dependent end-stage renal failure.
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